Halozyme Therapeutics (HALO) Change in Accrued Expenses (2009 - 2026)
Halozyme Therapeutics (HALO) posted Change in Accured Expenses of -$22.91 million for Q2 2026, compared with -$29.69 million a year earlier.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Halozyme Therapeutics was -$21.15 million; for FY2025, it came in at $6.21 million, down 86.8% from FY2024.
- In prior years, Halozyme Therapeutics' Change in Accured Expenses was $46.99 million in FY2024, -$12.55 million in FY2023, $24.54 million in FY2022 and $1.17 million in FY2021.
- Quarterly Change in Accured Expenses has run from a low of -$29.69 million in Q2 2025 to a high of $50.19 million in Q4 2024 over five years.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$24.92 million (Q1 2026), $33.85 million (Q4 2025) and -$7.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | 40.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 40.90 Mn |
| Jun 30, 2026 | -22.91 Mn |
| Mar 31, 2026 | -24.92 Mn |
| Dec 31, 2025 | 33.85 Mn |
| Sep 30, 2025 | -7.16 Mn |
| Jun 30, 2025 | -29.69 Mn |
| Mar 31, 2025 | 9.22 Mn |
| Dec 31, 2024 | 50.19 Mn |
| Sep 30, 2024 | -23.18 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 18.69 Mn |
| Dec 31, 2023 | -9.48 Mn |
| Sep 30, 2023 | -1.95 Mn |
| Jun 30, 2023 | 22.89 Mn |
| Mar 31, 2023 | -24.01 Mn |
| Dec 31, 2022 | 326,000.00 |
| Sep 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | 35.33 Mn |
| Mar 31, 2022 | -6.01 Mn |
| Dec 31, 2021 | 3.47 Mn |
API Access
Halozyme Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();